Company / FCF Margin
Evolent Health, Inc. FCF Margin History
FY2016-FY2019 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest FCF Margin
-11.4%
FY2019
5-year range
-
FY2016-FY2019
Trend
-18.5%
vs FY2018
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from -12.8% to -11.4% over the past 2 years.
Based on SEC 10-K filings.
-11.4% in FY2019 with a 3-year CAGR of +8.7%.
Improved from -12.8% to -11.4% over the past 2 years.
FCF Margin over time
Growth rates
- 3-Year Change
- +8.7pp
- 5-Year Change
- -
- 10-Year Change
- -
Key checks
Key Insights
- In FY2019, fcf margin decreased 18.5% year-over-year.
Company context
Key Data Points
- Altman Z-Score -0.84 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | FCF MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | -11.4% | -18.5% |
| FY2018 | -9.6% | +25.2% |
| FY2017 | -12.8% | +36.1% |
| FY2016 | -20.1% | +22.1% |
As of FY2019 · SEC Form 10-K · Last checked Jun 21, 2026